Ifm Investors Pty LTD Eli Lilly & CO Transaction History

Ifm Investors Pty LTD

$10.3 Billion
Q3 2024

A detailed history of Ifm Investors Pty LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Ifm Investors Pty LTD holds 167,316 shares of LLY stock, worth $122 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares

167,316

Previous 166,047 0.76%

Holding current value

$122 Million

Previous $150 Million 1.4%

% of portfolio

1.44%

Previous 1.53%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$772.14 - $960.02 $979,845 - $1.22 Million	1,269 Added 0.76%	167,316 $148 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $1.66 Million - $2.08 Million	2,292 Added 1.4%	166,047 $150 Million
Q1 2024 Apr 22, 2024	SELL	$592.2 - $792.28 $397,958 - $532,412	-672 Reduced 0.41%	163,755 $127 Million
Q4 2023 Jan 12, 2024	BUY	$525.19 - $619.13 $200,622 - $236,507	382 Added 0.23%	164,427 $95.8 Million
Q3 2023 Oct 26, 2023	BUY	$434.7 - $599.3 $2.08 Million - $2.87 Million	4,790 Added 3.01%	164,045 $88.1 Million
Q2 2023 Jul 27, 2023	BUY	$350.74 - $468.98 $2.88 Million - $3.85 Million	8,201 Added 5.43%	159,255 $74.7 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $1.43 Million - $1.67 Million	4,591 Added 3.13%	151,054 $51.9 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $2.1 Million - $2.45 Million	6,537 Added 4.67%	146,463 $53.6 Million
Q3 2022 Oct 12, 2022	BUY	$296.48 - $337.87 $578,728 - $659,522	1,952 Added 1.41%	139,926 $45.2 Million
Q2 2022 Jul 15, 2022	BUY	$278.73 - $327.27 $2.56 Million - $3.01 Million	9,201 Added 7.15%	137,974 $44.7 Million
Q1 2022 Apr 13, 2022	BUY	$234.69 - $291.66 $4.83 Million - $6 Million	20,566 Added 19.01%	128,773 $36.9 Million
Q4 2021 Jan 18, 2022	SELL	$224.85 - $279.04 $314,340 - $390,097	-1,398 Reduced 1.28%	108,207 $29.9 Million
Q3 2021 Oct 13, 2021	SELL	$221.6 - $272.71 $28,808 - $35,452	-130 Reduced 0.12%	109,605 $25.3 Million
Q2 2021 Jul 16, 2021	BUY	$180.55 - $233.54 $2.8 Million - $3.62 Million	15,510 Added 16.46%	109,735 $25.2 Million
Q1 2021 May 05, 2021	BUY	$164.32 - $212.72 $1.83 Million - $2.37 Million	11,125 Added 13.39%	94,225 $17.6 Million
Q4 2020 Jan 13, 2021	BUY	$130.46 - $172.63 $1.52 Million - $2.01 Million	11,661 Added 16.32%	83,100 $14 Million
Q3 2020 Oct 16, 2020	BUY	$146.22 - $169.13 $1.14 Million - $1.32 Million	7,807 Added 12.27%	71,439 $10.6 Million
Q2 2020 Jul 13, 2020	SELL	$136.42 - $164.18 $3.17 Million - $3.82 Million	-23,244 Reduced 26.76%	63,632 $10.4 Million
Q1 2020 Apr 09, 2020	SELL	$119.05 - $147.35 $393,460 - $486,991	-3,305 Reduced 3.66%	86,876 $12 Million
Q4 2019 Jan 13, 2020	SELL	$106.92 - $132.43 $524,870 - $650,098	-4,909 Reduced 5.16%	90,181 $11.9 Million
Q3 2019 Nov 01, 2019	BUY	$106.79 - $116.16 $3.34 Million - $3.64 Million	31,313 Added 49.1%	95,090 $10.6 Million
Q2 2019 Jul 16, 2019	BUY	$110.79 - $129.32 $61,710 - $72,031	557 Added 0.88%	63,777 $7.07 Million
Q1 2019 Apr 18, 2019	BUY	$111.31 - $131.02 $778,724 - $916,615	6,996 Added 12.44%	63,220 $8.2 Million
Q4 2018 Jan 23, 2019	BUY	$105.9 - $118.64 $501,436 - $561,760	4,735 Added 9.2%	56,224 $6.51 Million
Q3 2018 Oct 22, 2018	BUY	$85.86 - $107.31 $597,585 - $746,877	6,960 Added 15.63%	51,489 $5.53 Million
Q2 2018 Jul 09, 2018	BUY	$75.7 - $86.88 $1.03 Million - $1.18 Million	13,637 Added 44.14%	44,529 $3.8 Million
Q1 2018 May 11, 2018	BUY	$74.21 - $87.6 $226,563 - $267,442	3,053 Added 10.97%	30,892 $2.39 Million
Q4 2017 Jan 29, 2018	BUY	$81.94 - $87.89 $1,638 - $1,757	20 Added 0.07%	27,839 $2.35 Million
Q3 2017 Nov 16, 2017	BUY	$77.07 - $85.54 $46,627 - $51,751	605 Added 2.22%	27,819 $2.38 Million
Q2 2017 Aug 10, 2017	BUY	N/A	7,062 Added 35.04%	27,214 $2.24 Million
Q1 2017 Aug 17, 2017	BUY	N/A	20,152	20,152 $1.7 Million

Others Institutions Holding LLY

# of Institutions

4,002

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $691B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.

Account

Ifm Investors Pty LTD Eli Lilly & CO Transaction History